MD, MSc, MHA, Post-CCT Fellow in Endocrinology, Queen Elizabeth Hospital, University Hospitals Birmingham NHS Foundation Trust and Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, UNiversity of Birmingham, Birmingham, UK.

Αποφοίτησε από την Ιατρική Σχολή του ΕΚΠΑ το 2006. Ολοκλήρωσε την ειδίκευση του στην ειδικότητας της Ενδοκρινολογίας – Διαβήτη και Μεταβολισμού στην Ενδοκρινολογική Κλινική του Πανεπιστημιακού Νοσοκομείου Ιωαννίνων το 2017. Τον Αύγουστο του 2019 ολοκλήρωσε τη διετή εξειδίκευσή του στις παθήσεις της υπόφυσης στην Ενδοκρινολογική Κλινική του νοσοκομείου Queen Elizabeth, University Hospitals Birmingham NHS Foundation Trust και στο Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. Το ερευνητικό και κλινικό του ενδιαφέρον εστιάζεται στην Νευρο-ενδοκρινολογία και συγκεκριμένα στους υποφυσιακούς όγκους και στην υποφυσιακή ανεπάρκεια. Είναι κάτοχος δύο μεταπτυχιακών τίτλων σπουδών και έχει δημοσιεύσει αρκετά άρθρα σε διεθνή περιοδικά καθώς και κεφάλαια βιβλίων.

Papers

Frete C et al. Non-invasive Diagnostic Strategy in ACTH-dependent Cushing’s Syndrome. J Clin Endocrinol Metab

Walia R et al. Molecular Imaging Targeting Corticotropin ReleasingHormone Receptor for Corticotropinoma: A Changing Paradigm. J Clin Endocrinol Metab

Pivonello R et al. Efficacy and safety of osilodrostat in patients with Cushing’s disease (LINC 3): a multicentre phase III study with a double-blind, randomised withdrawal phase. Lancet Diabetes Endocrinol

Samson SLet al. Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide. J Clin Endocrinol Metab

Mazziotti Get al. Treatment of Acromegalic Osteopathy in Real-life Clinical Practice: The BAAC (Bone Active Drugs in Acromegaly) Study. J Clin Endocrinol Metab.

Giustina A et al. A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update. J Clin Endocrinol Metab

Geer EBet al. Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider

Fleseriu M et al. A Pituitary Society update to acromegaly management guidelines. Pituitary. 2020 Oct 20. doi: 10.1007/s11102-020-01091-7

Zamanipoor Najafabadi AHet al. Surgery as a Viable Alternative First-Line Treatment for Prolactinoma Patients. A Systematic Review and Meta-Analysis. J Clin Endocrinol Metab

KimDetal. Prolactin ≤1 ng/mL predicts macroprolactinoma reduction after cabergoline therapy.

De Sousa SMCet al. Impulse Control Disorders in Dopamine Agonist-Treated Hyperprolactinemia: Prevalence and Risk Factors. J Clin Endocrinol Metab

Han R et al. Diagnosing Thyrotropin-Secreting Pituitary Adenomas by Short-Term Somatostatin Analogue Test. Thyroid.

Marques P et al. Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors. J Clin Endocrinol Metab.

Freda PUet al. Presenting Features in 269 Patients With Clinically Nonfunctioning Pituitary Adenomas Enrolled in a Prospective Study.

Elbelt Uet al. Efficacy of Temozolomide Therapy in Patients With Aggressive Pituitary Adenomas and Carcinomas-A German Survey

van Santen SS et al. Body Composition and Bone Mineral Density in Craniopharyngioma Patients: A Longitudinal Study Over 10 Years. J Clin Endocrinol Metab.

van Santen SS et al. Body Composition and Bone Mineral Density in Craniopharyngioma Patients: A Longitudinal Study Over 10 Years. J Clin Endocrinol Metab.

Türe Uet al. Hypothalamitis: A Novel Autoimmune Endocrine Disease. A Literature Review and Case Report. J Clin Endocrinol Metab.

Sävendahl Let al.Long-term mortality after childhood growth hormone treatment: the SAGhE cohort study. Lancet Diabetes Endocrinol

Lu VMet al. Recurrence of Rathke’s cleft cysts based on gross total resection of cyst wall: a meta-analysis. Neurosurg Rev

Jullien Net al. Clinical lessons learned in constitutional hypopituitarism from two decades of experience in a large international cohort. Clin Endocrinol (Oxf).

Johannsson G et al. Once-weekly Somapacitan is Effective and Well Tolerated inAdults with GH Deficiency: A Randomized Phase 3 Trial. J Clin Endocrinol Metab.

Ebrahimi F et al.Excess Mortality Among Hospitalized Patients With Hypopituitarism-A Population-Based, Matched-Cohort Study.J Clin Endocrinol Metab.

Devuyst F et al. Central diabetes insipidus and pituitary stalk thickening in adults: distinction of neoplastic from non-neoplastic lesions. Eur J Endocrinol.

Bologna K et al. Effect of Arginine on the Hypothalamic-Pituitary-Adrenal Axis in Individuals With and Without Vasopressin Deficiency. J Clin Endocrinol Metab.

Newell-Price J et al. ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of Cushing’s syndrome. Eur J Endocrinol.

FleseriuM et al. Pituitary society guidance: pituitary disease management and patient care recommendations during the COVID-19 pandemic-an international perspective. Pituitary.

Christ-Crain M et al. ENDOCRINOLOGY IN THE TIME OF COVID-19: Management of diabetes insipidus and hyponatraemia. Eur J Endocrinol.